Twist Bioscience Corporation - Common Stock (TWST)
Frequently Asked Questions About Twist Bioscience Corporation - Common Stock (TWST)
Does Twist Bioscience offer services for academic institutions?
Yes, Twist Bioscience actively collaborates with academic institutions, providing access to its synthetic DNA synthesis services for research and educational purposes. The company supports academic research through tailored solutions that aid in various scientific investigations.
How can customers order from Twist?
Customers can place orders through Twist Bioscience's website, where they can select from a range of products and services. The online platform allows users to configure their order specifications and start their project seamlessly.
How does Twist contribute to sustainability?
Twist Bioscience addresses sustainability by enabling synthetic biology applications that can lead to environmental improvements. By providing tools for sustainable agricultural practices and bio-manufacturing, Twist helps reduce reliance on fossil fuels and promotes environmentally friendly alternatives.
How does Twist ensure the quality of its DNA synthesis?
Twist employs a rigorous quality control process, including in-process testing and validation of its DNA products. The company utilizes advanced analytics and proprietary algorithms to ensure the accuracy and reliability of synthesized DNA sequences.
How does Twist impact the field of synthetic biology?
Twist has significantly impacted synthetic biology by providing high-quality, custom-made synthetic DNA at scale. This capability empowers researchers and companies to accelerate their innovations, leading to new therapies, sustainable agricultural practices, and advancements in biochemical engineering.
How has Twist grown since its inception?
Since its founding, Twist Bioscience has experienced significant growth, expanding its product offerings and customer base. The company has also established partnerships with major pharmaceutical companies and research institutions, driving innovations in synthetic biology and related fields.
Is Twist Bioscience publicly traded?
Yes, Twist Bioscience Corporation is publicly traded on the Nasdaq stock exchange under the ticker symbol 'TWST'. The company completed its initial public offering (IPO) in 2018, allowing it to raise capital to fund its growth and further development of its technology.
What are some applications of Twist's DNA products?
Twist's DNA products are used in numerous applications such as vaccine development, gene editing, protein engineering, and development of diagnostic tests. The versatility of synthetic DNA allows researchers to explore new avenues in drug discovery and genetic research.
What are the key products offered by Twist Bioscience?
Twist Bioscience offers a range of products, including custom DNA synthesis, synthetic genes, gene fragments, and libraries. Additionally, the company provides tools for gene editing and optimization, enabling researchers to efficiently design and test biological components.
What are the recent developments at Twist Bioscience?
Recently, Twist Bioscience has announced several collaborations and advancements in its technology. This includes new partnerships to support vaccine development, advancements in gene therapy, and expanding its capabilities in DNA data storage.
What does Twist Bioscience Corporation do?
Twist Bioscience Corporation focuses on designing and manufacturing synthetic DNA and gene fragments. Utilizing its proprietary silicon-based DNA synthesis platform, Twist enables customers to create various applications, including synthetic biology, pharmaceutical development, diagnostics, and other biotechnology applications.
What financial performance has Twist Bioscience shown?
Twist Bioscience has demonstrated significant revenue growth since its IPO, reflecting increased demand for its products and services in the biotechnology market. The company's financial performance is regularly reported in quarterly earnings, showcasing its expansion and investments in technology.
What future trends does Twist foresee in the biotechnology industry?
Twist Bioscience anticipates trends toward personalized medicine, sustainable bio-manufacturing practices, and the integration of artificial intelligence in genetic research. The company aims to stay at the forefront of these trends by continually innovating and providing cutting-edge solutions.
What industries does Twist serve?
Twist serves various industries, including pharmaceuticals, synthetic biology, agriculture, diagnostics, and biotechnology. Its solutions cater to companies and research institutions seeking to leverage synthetic DNA for innovative applications in these fields.
What initiatives does Twist undertake in research and development?
Twist Bioscience invests heavily in research and development to enhance its DNA synthesis capabilities and explore new applications in synthetic biology. The company focuses on advancing its technology platform and expanding its product offerings to keep pace with industry demands.
What is the company’s vision?
Twist Bioscience's vision is to enable the future of genetic research and biotechnology by providing innovative and reliable DNA synthesis solutions. The company aims to empower scientists and researchers to harness the potential of synthetic biology for solving complex challenges in health, agriculture, and sustainability.
What is the technology behind Twist's DNA synthesis?
Twist's DNA synthesis technology is based on a unique silicon-based platform that allows for the precise and scalable production of synthetic DNA. This technology enhances the accuracy, cost-effectiveness, and throughput of DNA synthesis compared to traditional methods, enabling a wide range of applications.
What is Twist's business model?
Twist's business model is primarily based on providing custom synthetic DNA synthesis services and products to a diverse customer base, including academic institutions, pharmaceutical companies, and biotechnology firms. The company generates revenue by charging for its DNA products and services, often on a project basis.
When was Twist Bioscience founded?
Twist Bioscience was founded in 2013 by Emily Leproust, who was driven by the vision to revolutionize DNA synthesis and make it more accessible and cost-effective for researchers and companies in various fields, including healthcare and agriculture.
Where is Twist Bioscience headquartered?
Twist Bioscience is headquartered in San Francisco, California. The location provides a vibrant biotech ecosystem that fosters innovation and collaboration among researchers and companies in the field.
Who are Twist's main competitors?
Twist's main competitors include companies like Illumina, Ginkgo Bioworks, Integrated DNA Technologies (IDT), and Synthetic Genomics. These companies also operate in the synthetic biology and DNA synthesis market, focusing on similar applications and technology advancements.
What is the current price of Twist Bioscience Corporation - Common Stock?
The current price of Twist Bioscience Corporation - Common Stock is 38.21
When was Twist Bioscience Corporation - Common Stock last traded?
The last trade of Twist Bioscience Corporation - Common Stock was at 4:00 pm EDT on April 2nd, 2025
What is the market capitalization of Twist Bioscience Corporation - Common Stock?
The market capitalization of Twist Bioscience Corporation - Common Stock is 1.94B
How many shares of Twist Bioscience Corporation - Common Stock are outstanding?
Twist Bioscience Corporation - Common Stock has 50.89M shares outstanding.